ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Commercial Services

M3, Inc.

Business Summary

M3, Inc. engages in the provision of medical related services through the Internet. It operates through the following segments: Medical Portal, Evidence Solutions, Overseas, Clinical Platform, and Others. The Medical Portal segment provides the medical-related marketing support and research services. The Evidence Solutions segment includes clinical research support business, medical clinical trials management, and management support business. The Overseas segment offers marketing support and research services for medical-related firms in the United States, the United Kingdom, and South Korea. The Clinical Platform segment engages in the development, sale and support of electronic medical records. The Others segment offers information services for medical institutions and prescription drug advertising business. The company was founded on September 29, 2000 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue130,973M1,204.61M
Gross Profit69,761M641.62M
Operating income34,296M315.43M
Income before tax34,610M318.32M
Net income21,635M198.98M
EBITDA38,789M356.75M
Diluted EPS31.870.29
Dividends Per Share8.500.07
Total Assets221,839M2,054.92M
Total liabilities50,238M465.36M
Total equity166,111M1,538.70M
Operating cash flow26,789M246.39M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 64,660M 78,143M 94,471M 113,059M 130,973M
Gross Profit 37,152M 45,444M 53,016M 62,884M 69,761M
Operating income 19,309M 23,985M 26,907M 27,837M 34,296M
Income before tax 19,950M 24,959M 27,472M 30,942M 34,610M
Net income 12,508M 16,004M 18,127M 19,577M 21,635M
EBITDA 20,175M 24,924M 28,068M 29,228M 38,789M
Diluted EPS 19.30 24.70 13.98 30.20 31.87
Dividends Per Share 4.50 5 5.50 7 8.50
Total Assets 73,642M 95,546M 116,441M 137,306M 221,839M
Total liabilities 17,080M 26,021M 31,272M 35,029M 50,238M
Total equity 54,889M 67,064M 82,483M 98,733M 166,111M
Operating cash flow 12,136M 16,555M 15,913M 17,749M 26,789M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 538.45M 721.62M 852.37M 1,019.51M 1,204.61M
Gross Profit 309.38M 419.66M 478.34M 567.06M 641.62M
Operating income 160.79M 221.49M 242.77M 251.02M 315.43M
Income before tax 166.13M 230.48M 247.86M 279.02M 318.32M
Net income 104.16M 147.79M 163.55M 176.53M 198.98M
EBITDA 168.00M 230.16M 253.24M 263.56M 356.75M
Diluted EPS 0.16 0.22 0.12 0.27 0.29
Dividends Per Share 0.03 0.04 0.04 0.06 0.07
Total Assets 655.20M 857.45M 1,094.88M 1,240.51M 2,054.92M
Total liabilities 151.96M 233.51M 294.04M 316.47M 465.36M
Total equity 488.35M 601.84M 775.58M 892.01M 1,538.70M
Operating cash flow 101.06M 152.88M 143.57M 160.05M 246.39M

Valuation Measures

Mar 2020
PER100.19
ROA12.04%
ROE16.33%
Operating margin26.18%
Profit margin16.51%

Key executives

  • President & Representative Director: Itaru Tanimura

Shareholders

  • Sony Corp. (33.9%)
  • Baillie Gifford & Co. (9.2%)
  • Nomura Asset Management Co., Ltd. (5.8%)
  • Harding Loevner LP (3.3%)
  • JPMorgan Asset Management (Japan) Ltd. (3.0%)
  • NTT DoCoMo, Inc. (2.9%)
  • Nikko Asset Management Co., Ltd. (2.8%)
  • TANIMURA ITARU (2.8%)
  • Daiwa Asset Management Co. Ltd. (2.4%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.1%)

Contact Details

  • Website:http://corporate.m3.com/
  • Address: Akasaka Intercity, 10/F, 1-11-44 Akasaka, Tokyo, 107-0052, Japan
  • Phone: +81.3.6229.8900

Related Companies

  • Vidal France SA
  • M3 (EU) Ltd.
  • M3 Medical Holdings Ltd.
  • Medical Agency KK
  • Edanz Group Japan, Inc.
  • Neuroglia Health Pvt Ltd.
  • Shin Nippon Biomedical Laboratories SMO Ltd.
  • iG-Holdings, Inc. (Japan)
  • M3 Doctor Support, Inc.
  • M3i, Inc.
  • Clinical Porter, Inc.
  • Nouvelle Place, Inc.
  • M3 Marketing, Inc.
  • DailyRounds, Inc.
  • e- SMO KK
  • M Cube, Inc.
  • Fuji CRS KK
  • QLife, Inc.
  • M3 USA Corp.
  • Medi C&C Co., Ltd.
  • C.M.S Co. Ltd.
  • Nihon Ultmarc, Inc.
  • Cosmotec Co., Ltd.
  • SmartestDoc LLC
  • Neues Co. Ltd.
  • Manthan Software Services Pvt Ltd.
  • MIC Medical Corp.
  • MDLinx, Inc.
  • Mebix, Inc.
  • Mediscience Planning Inc.

Competitors

    Last Updated on 1 Jun, 2020

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

    Stay ahead with our exclusives on Asia;
    the most dynamic market in the world.

    Stay ahead with our exclusives on Asia

    Get trusted insights from experts within Asia itself.

    Get trusted insights from experts
    within Asia itself.

    Get Unlimited access

    You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

    This is your last free article this month

    Stay ahead with our exclusives on Asia; the most
    dynamic market in the world
    .

    Get trusted insights from experts
    within Asia itself.

    Try 3 months for $9

    Offer ends April 30th

    Your trial period has expired

    You need a subscription to...

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers and subscribe

    Your full access to the Nikkei Asian Review has expired

    You need a subscription to:

    • Read all stories with unlimited access
    • Use our mobile and tablet apps
    See all offers
    NAR on print phone, device, and tablet media